AI3-04461 en es it fr

AI3-04461 Brand names, AI3-04461 Analogs

AI3-04461 Brand Names Mixture

  • No information avaliable

AI3-04461 Chemical_Formula


AI3-04461 RX_link

No information avaliable

AI3-04461 fda sheet

AI3-04461 msds (material safety sheet)$FILE/English.pdf

AI3-04461 Synthesis Reference

No information avaliable

AI3-04461 Molecular Weight

133.104 g/mol

AI3-04461 Melting Point

230 oC

AI3-04461 H2O Solubility

4.5 g/l

AI3-04461 State


AI3-04461 LogP

-0.67 +/- 0.36

AI3-04461 Dosage Forms

Capsules and powder

AI3-04461 Indication

There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.

AI3-04461 Pharmacology

L-aspartate is considered a non-essential amino acid, meaning that, under normal physiological conditions, sufficient amounts of the amino acid are synthesized in the body to meet the body's requirements. L-aspartate is formed by the transamination of the Krebs cycle intermediate oxaloacetate. The amino acid serves as a precursor for synthesis of proteins, oligopeptides, purines, pyrimidines, nucleic acids and L-arginine. L-aspartate is a glycogenic amino acid, and it can also promote energy production via its metabolism in the Krebs cycle. These latter activities were the rationale for the claim that supplemental aspartate has an anti-fatigue effect on skeletal muscle, a claim that was never confirmed.

AI3-04461 Absorption

Absorbed from the small intestine by an active transport process

AI3-04461 side effects and Toxicity

Mild gastrointestinal side effects including diarrhea. LD50 (rat) > 5,000 mg/kg.

AI3-04461 Patient Information

No information avaliable

AI3-04461 Organisms Affected

Humans and other mammals